Contrast-enhanced ultrasound manifestations of synchronous combined hepatocellular-cholangiocarcinoma and hepatocellular carcinoma:A case report

被引:0
|
作者
Ling Gao [1 ,2 ]
Jia-Yan Huang [1 ]
Zi-Jian Lu [3 ]
Qiang Lu [1 ]
机构
[1] Department of Ultrasound, West China Hospital, Sichuan University
[2] Department of Ultrasound, Chengdu BOE hospital
[3] Department of Pathology, West China Hospital, Sichuan University
关键词
D O I
暂无
中图分类号
R735.8 [胆囊、胆道肿瘤]; R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
BACKGROUND Synchronous combined hepatocellular-cholangiocarcinoma(CHC) and hepatocellular carcinoma(HCC) is very rare, with few literature reports and poor clinical outcomes associated with the disorder. Surgical resection is the main treatment, which makes the preoperative diagnosis very important. However, due to imaging manifestations overlapping with HCC, diagnosis of this type of synchronous cancer is challenging and it tends to be misdiagnosed as multiple HCC. Herein, we report the contrast-enhanced ultrasound(CEUS) manifestations of a case of synchronous CHC and HCC, aiming at adding to the understanding of this disease. CEUS displayed exquisite vascularity and tissue perfusion in real time with good spatial and temporal resolution and more accurately reflect tumor washin and washout times than contrast-enhanced computed tomography(CT) in this case.CASE SUMMARY The patient was a 69-year-old female with a 20-year history of chronic hepatitis B. Due to months of epigastric pain and anorexia, she reffered to our hospital for treatment. Five days before hospitalization, abdominal magnetic resonance imaging performed at another hospital detected a space-occupying lesion in the liver. After her hospitalization, laboratory tests showed elevated alpha-fetoprotein and carbohydrate antigen 19-9 level. Two suspicious liver lesions located in S4 and S6, respectively, were identified in a cirrhotic background by abdominal contrast-enhanced CT(CECT). Furthermore, the lesion in S4 and S6 were detected by CEUS and assigned to CEUS LI-RADS 5 and M categories, respectively. The patient underwent tumor radical resections. Post-operative pathology confirmed the S4 and S6 lesions to be HCC and CHC, respectively. A newly-found suspicious liver nodule with potential malignancy was detected in liver S1 by both CEUS and CECT 7 mo after operation.CONCLUSION The CEUS characteristics of CHC and HCC are different. CEUS features in combination with clinical information could help in effective diagnosis, clinical decision-making and better prognosis.
引用
收藏
页码:3615 / 3623
页数:9
相关论文
共 50 条
  • [41] Combined hepatocellular-cholangiocarcinoma with angiosarcomatoid change: A case report with immunohistochemical study
    Hakozaki, Mayu
    Ito, Shinji
    Fujii, Takeshi
    Kiya, Yoshitaka
    Udagawa, Harushi
    Fukayama, Masashi
    Fukusato, Toshio
    PATHOLOGY INTERNATIONAL, 2019, 69 (02) : 110 - 116
  • [42] Cytokeratin profiles and mucin secretion in combined hepatocellular-cholangiocarcinoma - A case report
    Hauben, E
    Struyf, N
    Michielsen, P
    VanMarck, E
    PATHOLOGY RESEARCH AND PRACTICE, 1996, 192 (05) : 488 - 491
  • [43] Resection of Mixed Hepatocellular-Cholangiocarcinoma, Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma
    Holzner, Matthew L.
    Tabrizian, Parissa
    Parvin-Nejad, Fatemeh P.
    Fei, Kezhen
    Gunasekaran, Ganesh
    Rocha, Chiara
    Facciuto, Marcelo E.
    Florman, Sander
    Schwartz, Myron E.
    LIVER TRANSPLANTATION, 2020, 26 (07) : 888 - 898
  • [44] Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography
    Li, Rui
    Yang, Dan
    Tang, Chun-Lin
    Cai, Ping
    Ma, Kuan-sheng
    Ding, Shi-Yi
    Zhang, Xiao-Hang
    Guo, De-Yu
    Yan, Xiao-Chu
    BMC CANCER, 2016, 16
  • [45] Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography
    Rui Li
    Dan Yang
    Chun-Lin Tang
    Ping Cai
    Kuan-sheng Ma
    Shi-Yi Ding
    Xiao-Hang Zhang
    De-Yu Guo
    Xiao-Chu Yan
    BMC Cancer, 16
  • [46] Contrast-Enhanced Ultrasound in the Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Controversy over the ASSLD Guideline
    Guo, Le-Hang
    Xu, Hui-Xiong
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [47] Nestin Expression in Combined Hepatocellular-cholangiocarcinoma and Hepatocellular Carcinoma and its Prognostic Significance
    Kwon, Minji
    Kim, Haeryoung
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1377 - S1378
  • [48] Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma
    Joseph, Nancy M.
    Tsokos, Christos G.
    Umetsu, Sarah E.
    Shain, A. Hunter
    Kelley, Robin K.
    Onodera, Courtney
    Bowman, Sarah
    Talevich, Eric
    Ferrell, Linda D.
    Kakar, Sanjay
    Krings, Gregor
    JOURNAL OF PATHOLOGY, 2019, 248 (02): : 164 - 178
  • [49] Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma
    Sagrini, Elisabetta
    Iavarone, Massimo
    Stefanini, Federico
    Tovoli, Francesco
    Vavassori, Sara
    Maggioni, Marco
    Renzulli, Matteo
    Salvatore, Veronica
    Stefanescu, Horia
    Colombo, Massimo
    Bolondi, Luigi
    Piscaglia, Fabio
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2019, 7 (01) : 69 - 77
  • [50] Cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in cirrhotic patients
    Salinas, Marcelo
    Simian, Daniela
    Carreno, Laura
    Cattaneo, Maximo
    Urzua, Alvaro
    Saure, Alex
    Lembach, Hanns
    Castillo, Jaime
    Diaz, Juan C.
    Poniachik, Jaime
    REVISTA MEDICA DE CHILE, 2022, 150 (11) : 1431 - 1437